Physician profile

Jeffrey Scott Bobst

Oral and Maxillofacial Surgery · Chandler, AZ

NPI 1275747859

$7,467.64

in general payments reported to CMS, 2019-2025

3 companies · $3,845 in 2025

The $3,845 reported for 2025 was more than what 96% of Oral and Maxillofacial Surgery providers received nationally (typical 2025 total: $150).

See the full distribution for Oral and Maxillofacial Surgery

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$2,164.48
Travel and Lodging$2,057.60
Gift$100.00
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program$43.68

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Straumann USA LLC $7,306.42 2019-2025
Nobel Biocare USA $145.41 2019-2021
Zimmer Biomet Holdings, INC. $15.81 2021

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Jeffrey Scott Bobst

$7,467.64

in general payments reported 2019-2025

Years
2019-2025
Top company
Straumann USA LLC
Context
The $3,845 reported for 2025 was more than what 96% of Oral and Maxillofacial Surgery providers received nationally (typical 2025 total: $150).

https://glasscript.com/doctor/1112334/jeffrey-scott-bobst

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.